| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Foundation for the future
|
Ludwig, H.
|
|
|
16 |
1 |
p. 3
|
artikel
|
| 2 |
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)
|
Ballova, V.
|
|
|
16 |
1 |
p. 124-131
|
artikel
|
| 3 |
A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)—the 4th study
|
Nakagawa, M.
|
|
|
16 |
1 |
p. 75-80
|
artikel
|
| 4 |
Cancer genetic counselling
|
Mandich, P.
|
|
|
16 |
1 |
p. 171
|
artikel
|
| 5 |
Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers
|
Toyoki, H.
|
|
|
16 |
1 |
p. 51-55
|
artikel
|
| 6 |
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
|
Josting, A.
|
|
|
16 |
1 |
p. 116-123
|
artikel
|
| 7 |
Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?
|
Crawford, S.M.
|
|
|
16 |
1 |
p. 47-50
|
artikel
|
| 8 |
Extended rituximab therapy in Waldenström's macroglobulinemia
|
Treon, S.P.
|
|
|
16 |
1 |
p. 132-138
|
artikel
|
| 9 |
Impact of EGFR expression on colorectal cancer patient prognosis and survival
|
Spano, J.-P.
|
|
|
16 |
1 |
p. 102-108
|
artikel
|
| 10 |
Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma
|
Ling, C.-Q.
|
|
|
16 |
1 |
p. 109-115
|
artikel
|
| 11 |
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study
|
von Minckwitz, G.
|
|
|
16 |
1 |
p. 56-63
|
artikel
|
| 12 |
Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience
|
Tsimberidou, A.-M.
|
|
|
16 |
1 |
p. 139-145
|
artikel
|
| 13 |
Macronutrients, fatty acids, cholesterol and prostate cancer risk
|
Bidoli, E.
|
|
|
16 |
1 |
p. 152-157
|
artikel
|
| 14 |
Neoplastic Diseases of the Blood
|
Hossfeld, D.K.
|
|
|
16 |
1 |
p. 175
|
artikel
|
| 15 |
Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
|
Welt, A.
|
|
|
16 |
1 |
p. 64-69
|
artikel
|
| 16 |
Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors
|
Moiseyenko, V.M.
|
|
|
16 |
1 |
p. 162-168
|
artikel
|
| 17 |
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)
|
Gervais, R.
|
|
|
16 |
1 |
p. 90-96
|
artikel
|
| 18 |
Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer
|
Lilenbaum, R.C.
|
|
|
16 |
1 |
p. 97-101
|
artikel
|
| 19 |
Phase II study of E7070 in patients with metastatic melanoma
|
Smyth, J.F.
|
|
|
16 |
1 |
p. 158-161
|
artikel
|
| 20 |
Principles of Molecular Oncology
|
Fey, M.F.
|
|
|
16 |
1 |
p. 175-176
|
artikel
|
| 21 |
Prognostic factors in ovarian cancer: how close are we to a complete picture?
|
Agarwal, R.
|
|
|
16 |
1 |
p. 4-6
|
artikel
|
| 22 |
Proteomic analysis for the early detection and rational treatment of cancer—realistic hope?
|
Posadas, E.M.
|
|
|
16 |
1 |
p. 16-22
|
artikel
|
| 23 |
Recommendations for a Global Core Curriculum in Medical Oncology Ann Oncol 2004; 15: 1603–1612
|
Hansen, H.H.
|
|
|
16 |
1 |
p. 177
|
artikel
|
| 24 |
Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens
|
Amato, R.J.
|
|
|
16 |
1 |
p. 7-15
|
artikel
|
| 25 |
Reply to “Early subcutaneous wash-out in acute extravasations”, by R. Giunta (Ann Oncol 2004; 15: 1146), and to the reply by D. Schrijvers (Ann Oncol 2004; 15: 1147)
|
Chacon, M.R.
|
|
|
16 |
1 |
p. 170
|
artikel
|
| 26 |
Retroperitoneal lymph node dissection versus chemotherapy for stage I testicular nonseminomas
|
Gilligan, T.
|
|
|
16 |
1 |
p. 172-173
|
artikel
|
| 27 |
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience
|
De Giorgi, U.
|
|
|
16 |
1 |
p. 146-151
|
artikel
|
| 28 |
Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study
|
Douillard, J.-Y.
|
|
|
16 |
1 |
p. 81-89
|
artikel
|
| 29 |
Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia
|
Tognoni, G.
|
|
|
16 |
1 |
p. 169-170
|
artikel
|
| 30 |
Table of Contents
|
|
|
|
16 |
1 |
p. i-iii
|
artikel
|
| 31 |
Teenage kicks
|
Kerr, D.J.
|
|
|
16 |
1 |
p. 1-2
|
artikel
|
| 32 |
The Global Challenge of Colorectal Cancer. Reports from the UICC International Workshop on Facilitating Screening for Colorectal Cancer: An International Agenda
|
Levin, B.
|
|
|
16 |
1 |
p. 23
|
artikel
|
| 33 |
Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients
|
Morales, L.
|
|
|
16 |
1 |
p. 70-74
|
artikel
|
| 34 |
Touch imprint cytologic preparations and the diagnosis of head and neck mass lesions
|
Hussein, M.R.
|
|
|
16 |
1 |
p. 171-172
|
artikel
|
| 35 |
Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
|
Boyle, P.
|
|
|
16 |
1 |
p. 25-30
|
artikel
|
| 36 |
Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
|
Patnick, J.
|
|
|
16 |
1 |
p. 34-37
|
artikel
|
| 37 |
Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
|
Winawer, S.
|
|
|
16 |
1 |
p. 31-33
|
artikel
|
| 38 |
Workgroup IV: public education. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
|
Hiatt, R.
|
|
|
16 |
1 |
p. 38-41
|
artikel
|
| 39 |
Workgroup V: professional education and advocacy. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
|
Rozen, P.
|
|
|
16 |
1 |
p. 42-45
|
artikel
|
Tijdschrift beschrijving